Moreover, in vivo and in vitro studies showed that the GLP-1 receptor analogue exendin 4 enhanced prostate cancer response to ionizing radiation (IR) via induction of G2–M cycle arrest in prostate cancer cells in a dose-dependent manner [68] (Figure 1). This evidence concerns the gene GLP1R and prostate carcinoma.